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RANTES, a b-chemokine, can suppress human immunodeficiency virus (HIV) as well as simian immunodeficiency virus
(SIV) infections in T-lymphocyte cultures in vitro. However, the association of RANTES levels in peripheral blood with viral
loads and disease outcome in HIV infection has been inconclusive. SIV-infected rhesus macaques were evaluated to
determine whether RANTES gene expression correlated with suppression of viral infection in intestinal lymphoid tissues.
Intestinal tissues were obtained from rhesus macaques infected with either pathogenic or nonpathogenic SIVmac variants
at various stages of infection (primary acute, asymptomatic, and terminal). We examined the level of SIV infection (in situ
hybridization), RANTES expression (quantitative competitive RT-PCR), and T-cell counts (immunohistochemistry). The most
pronounced increase in RANTES gene expression in intestinal tissues was observed in primary SIV infection, which
correlated with the pathogenicity of the infecting virus and not the tissue viral loads. Our results demonstrated that in
contrast to the occurrence of viral suppression by RANTES in vitro, there was no direct correlation between high RANTES
gene expression and suppression of viral loads in intestinal lymphoid tissues. Thus RANTES expression in the gut lymphoid
tissue may not be a correlate for viral suppression. However, RANTES gene expression in primary SIV infection may be part
of early host immune response to viral infection. © 1999 Academic Press
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tINTRODUCTION
The variable disease course characteristic of human
mmunodeficiency virus (HIV) infection can be attributed
o a combination of both viral and host factors (Fauci,
996). The b-chemokines, namely regulated-upon-activa-
ion normal T-cell-expressed and -secreted (RANTES),
acrophage inflammatory protein-1a and -b (MIP-1a
nd MIP-1b) were shown to suppress human immuno-
eficiency virus (HIV-1 and -2) and simian immunodefi-
iency virus (SIV) infections in CD41 T lymphocyte cul-
ures in vitro (Castro et al., 1991; Cocchi et al., 1995, 1996;
aliard et al., 1996). b-chemokines are known to induce
elective recruitment, migration, and activation of spe-
ific subsets of leukocytes to sites of inflammation in-
uced by various pathogenic infections (Adams and
loyd, 1997). Therefore, b-chemokines may be an impor-
ant component in the induction of efficient cell-mediated
nd humoral immune responses to infections by modu-
ation of cellular trafficking (Schall and Bacon, 1994).
owever, the suppression of HIV and SIV infections by
hese chemokines could be largely attributed to their
bility to bind to chemokine receptors CCR4 and CCR5.
ased on these observations, it was assumed that the
hemokine levels may be one of the correlates of the
ong-term survival in HIV infection. HIV-1-infected non-
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110rogressors had levels of RANTES, MIP-1a, and MIP-1b
imilar to those of uninfected controls, whereas other
nvestigators found lower levels of circulating b-chemo-
ines in HIV-1-infected patient populations whose viral
oads ranged from high to low (Kakkanaiah et al., 1998;
inter et al., 1998; Paxton et al., 1996). In vitro cultures of
-cell clones derived from PBMC of long-term nonpro-
ressors were shown to secret high levels of RANTES,
IP-1b, and MIP-1a (Scala et al., 1997). Thus studies on
hemokine levels in peripheral blood samples in HIV
nfection have not been conclusive.
Although most of the studies on chemokine expres-
ion in HIV infection have been performed in peripheral
lood, blood represents only 2% of all the lymphocytes in
he body. The gut-associated lymphoid tissue (GALT),
eing the largest lymphoid organ in the body, harbors
ore than 90% of the lymphocytes. Therefore it can be an
mportant early target organ and a site for initial host–
irus interactions as well as for persistent viral infection.
he GALT provides a microenvironment conducive for
ctive viral replication since it harbors a large proportion
f activated lymphocytes and can be a significant viral
eservoir. The substantial involvement of the intestinal
ucosa in HIV infection is evidenced by high viral loads
n intestinal tissues and a high frequency of gastrointes-
inal complications in HIV-infected patients as well as
IV-infected rhesus macaques (Heise et al., 1991; Pan-
aleo et al., 1991; Schneider, et al., 1997). There is no
nformation available on intestinal chemokine expres-
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111RANTES GENE EXPRESSION IN SIV INFECTIONion in early stages of HIV infection. Alterations in che-
okine expression in peripheral blood may not ade-
uately reflect changes in the intestinal mucosa follow-
ng HIV infection. These compartments differ in the
umbers and phenotypes of activated and differentiated
-cell subpopulations and thus necessitate examination
f viral–host interactions in these compartments inde-
endently. Studies of this nature have been limited due to
he difficulty in obtaining intestinal tissue samples in
ufficient quantities in early stages of HIV infection.
The SIV-infected rhesus macaques provide a suitable
nimal model for studies on the early host–viral interac-
ions and immunopathogenic studies on the mucosal
ymphoid tissue. Availability of molecularly cloned,
athogenic SIVmac 239 and nonpathogenic SIVmac
A11 variants, as well as the biologic isolate SIVmac 251,
as facilitated these studies (Kestler et al., 1990; Marthas
t al., 1989, 1990). Both SIVmac 251 and SIVmac 239
ause simian AIDS in rhesus macaques, whereas
IVmac1A11 does not cause any disease (Gardner et al.,
996; Lohman et al., 1994; Otsyula et al., 1996; Van
ompay et al., 1996).
We sought to examine whether RANTES gene expres-
ion correlated with viral suppression and CD31 T-cell
revalence in intestinal mucosa during the course of
athogenic or nonpathogenic SIV infection. We sought to
xamine RANTES expression, since RANTES alone is
apable of suppressing HIV infection while the other
embers of the b-chemokine subfamily, MIP-1a and
IP-1b, exert HIV suppressor activity only in combina-
ion with RANTES (Cocchi et al., 1996). We hypothesized
hat high RANTES gene expression in intestinal mucosa
ay correlate with low viral load and high CD31 T-cell
ounts in the intestine and the pathogenicity of the in-
ecting virus. We tested this hypothesis by examining
iral infection (in situ hybridization), RANTES gene ex-
ression (quantitative competitive RT-PCR), and preva-
ence of CD31 T lymphocytes (immunohistochemistry) in
ntestinal mucosa of rhesus macaques infected with ei-
her pathogenic SIVmac 239/SIVmac 251 or nonpatho-
enic SIVmac 1A11 during the primary acute, asymptom-
tic, and terminal phases of disease progression and
ompared them with results from uninfected healthy an-
mals. Our studies showed that the magnitude of in-
rease in RANTES gene expression correlated with the
athogenicity of the infecting virus and not with either
iral suppression or CD31 T-cell prevalence in the GALT.
hese results demonstrated that RANTES gene expres-
ion in SIV-infected intestinal lymphoid tissues may not
e a correlate of viral suppression in vivo.
RESULTS
etection of SIV infection in intestinal mucosa
Dissemination and localization of SIV-infected cells in
ntestinal mucosa were determined by in situ hybridiza- eion. The number of SIV-infected cells and their localiza-
ion varied depending on the pathogenicity of the infect-
ng SIV isolate and the stage of infection. Animals in-
ected with pathogenic SIV isolates (SIVmac 239 or
IVmac 251) had high numbers of infected cells (5 SIV
nfection scores) during the primary acute and SAIDS
hases of infection. However, relatively low numbers of
nfected cells (less than 2 SIV infection scores) were
bserved during the asymptomatic phase (4 and 8
eeks postinfection (p.i.)) in all asymptomatic stage an-
mals. The SIV mac 1A11-infected animals displayed low
IV infection scores (0–2 SIV infection scores). The lo-
alization of SIV-infected cells in the jejunal mucosal
ymphoid tissue differed between pathogenic and non-
athogenic SIV isolates. In SIVmac 251- and SIVmac
39-infected animals, SIV-positive cells were widely dis-
eminated in the lamina propria, in Peyer’s patches, and
n lymphoid aggregates. Infected cells were also ob-
erved in germinal centers and paracortical regions of
eyer’s patches. In the SAIDS animals, SIV-infected cells
ere found to be widely distributed in the intestinal
ucosa. In the SIVmac 1A11-infected animals, SIV-posi-
ive cells were primarily localized at germinal centers.
ANTES gene expression during various stages
f infection
Expression of RANTES mRNA in jejunal tissues during
rimary acute, asymptomatic, and SAIDS stages of SIV
nfection was determined by the quantitative-competitive
T-PCR (QC-RT-PCR) assay and compared with the lev-
ls observed in uninfected healthy controls. The expres-
ion of GAPDH, a housekeeping gene, was also deter-
ined in the same RNA samples. GAPDH mRNA was
ound to be constitutively expressed at 1–2 3 1017 copies
er microgram of tissue RNA irrespective of the disease
tatus of the animals (Figs. 1B and 1C). The level of
ANTES mRNA in all three uninfected controls was de-
ermined to be 1–6 3 104 copies per microgram of jejunal
NA. A consistent increase in RANTES gene expression
n the intestinal tissue was observed in primary SIV
nfection with either pathogenic or nonpathogenic SIV
ompared to uninfected controls. The magnitude of in-
rease in RANTES expression correlated with the patho-
enicity of the infecting virus. The RANTES mRNA levels
ere consistently higher (a 500-fold increase or 5 log
ifference) in the SIVmac 251- or SIVmac239-infected
nimals during the primary acute stage (1–2 weeks p.i.)
ompared to uninfected controls and SIVmac 1A11-in-
ected animals (Figs. 2C and 3C). In the asymptomatic
tage, a decline in RANTES expression was observed in
oth pathogenic and nonpathogenic SIV infection. Ani-
als with SAIDS also showed high levels of RANTESxpression.
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112 NDOLO ET AL.ANTES expression and SIV infection in intestine
Animals infected with SIV mac 1A11 had consistently
ower numbers of SIV-infected cells (0–2 SIV infection
cores) during primary viral infection than animals in-
ected with the pathogenic isolates as determined by in
itu hybridization (Fig. 2A). These animals also had rel-
tively low levels of RANTES mRNA expression ranging
rom 104 to 105 copies per microgram of total RNA.
FIG. 1. Quantitation of RANTES and GAPDH mRNA by QC-RT-PCR
ANTES-specific and GAPDH-specific primers were designed and us
aterials and Methods. Expression of GAPDH mRNA in jejunal tissue
C-RT-PCR analysis. Total RNA was aliquoted into seven replicates (0.1
imic RNA (lane 1, 500,000; lane 2, 50,000; lane 3, 25,000; lane 4, 10,00
n a 3% ethidium agarose gel. The 527- and 340-bp bands correspond
IH imaging and Collage software. The expression of GAPDH mRNA
ANTES mRNA in jejunal tissues of uninfected (D) and SIV-infected (E) r
o the uninfected macaque RNA samples (D) (lane 1, 500,000; lane 2, 50,0
nd SIV-infected RNA samples (E) (lane 1, 7 3 107; lane 2, 6 3 107; lan
opies). The 342- and 192-bp bands correspond to RANTES mimic and
n jejunal tissues of SIV infected animals compared to uninfected conIV-positive cells were not detectable in the intestinal lissues by in situ hybridization in two animals at 1 week
.i. (primary acute) and 23 weeks p.i. (asymptomatic
tage). The RANTES mRNA levels in these animals were
omparable to those in the uninfected controls. Thus a
ow SIV infection in nonpathogenic SIV infection did not
ead to any significant increase in the levels of RANTES
RNA. In animals infected with pathogenic SIV isolates,
any SIV-infected cells were detected at 1 week p.i. The
hematic presentation of the construction of mimic RNA. Composite,
construct the internal competitor or mimic RNA as described under
infected (B) and SIV-infected rhesus macaques (C) as determined by
h) and respective reactions were spiked with serial dilution competitor
5, 5000; lane 6, 1000; lane 7, 500 copies). PCR products were resolved
GAPDH and mimic PCR products, respectively, were quantified using
ed unaltered in both infected and uninfected animals. Expression of
acaques. For RANTES quantitation, competitor mimic RNA was added
e 3, 25,000; lane 4, 10,000; lane 5, 5000; lane 6, 1000; lane 7, 500 copies)
107; lane 4, 4 3 107; lane 5, 3 3 107; lane 6, 3 3 107; lane 7, 1 3 107
ES, respectively. Enhanced RANTES mRNA expression was observed. (A) Sc
ed to
s of un
mg eac
0; lane
ing to
remain
hesus m
00; lan
e 3, 5 3
RANTevel of SIV infection remained similar or increased in
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113RANTES GENE EXPRESSION IN SIV INFECTIONnimals at 2 weeks p.i. (Fig. 3A). Animals with high SIV
nfection scores at both 1 and 2 weeks p.i. during primary
IV infection also showed high RANTES mRNA levels. In
ne of the six animals with primary pathogenic SIV in-
8
FIG. 2. The level of SIV infection (A), CD31 T-cell counts (B), and
ANTES mRNA expression (C) in jejunal tissues of rhesus macaques
nfected with nonpathogenic SIV isolate. In situ hybridization, immuno-
taining, and QC-RT-PCR were used to determine SIV infection scores,
ell counts, and RANTES mRNA expression, respectively.ection, a high level of RANTES mRNA expression, 10 iopies per microgram of RNA, accompanied by a low SIV
nfection score (1 SIV infection score) was detected in
ne animal at 1 week p.i. Animals in the asymptomatic
tage (4 and 8 weeks p.i.), showed low to moderate SIV
nfection scores but had elevated RANTES mRNA ex-
ression, 106–108 copies compared to 104 copies in un-
nfected controls and SIV mac 1A11-infected animals at
3 and 23 weeks p.i. Only one of the four animals with
AIDS showed enhanced RANTES mRNA expression
109 copies) and a moderate SIV infection score (,2 SIV
nfection scores). Another animal with SAIDS had low SIV
nfection score and RANTES mRNA levels comparable to
hose of the uninfected controls. The remaining two an-
mals with SAIDS displayed high SIV infection scores
nd high levels of RANTES mRNA (Fig. 3A).
ANTES expression and CD31 T-cells in intestinal
pithelium and lamina propria at different stages of
isease progression
To determine the relationship between RANTES gene
xpression and CD31 T-cell prevalence in the intraepi-
helial and lamina propria compartments of intestinal
ucosa during primary SIV infection, immunohistochem-
cal analysis was performed on jejunal tissues from an-
mals infected with pathogenic or nonpathogenic SIV
solates and uninfected controls. In uninfected control
nimals, 100–200 CD31 T-cells/mm of villus were ob-
erved in lamina propria while less than 100 CD31 T-
ells/mm of villus were scored in the villus epithelium.
uring the primary SIV infection, a significant increase in
he number of CD31 T cells in the lamina propria (345
nd 518 CD31 cells/mm of villus) was seen in the jejunal
ucosa of SIVmac 1A11-infected animals at 1 and 2
eeks p.i., respectively (Fig. 2B). However, CD31 T-cell
ounts in the asymptomatic stage (13 and 23 weeks p.i.)
ere similar to those in uninfected controls. In the patho-
enic SIV-infected animals, relatively low CD31 T-cell
umbers were seen in both the intraepithelial and the
amina propria compartments in the primary infection
tarting at 1 week p.i. CD31 T-cell counts in both com-
artments remained low during the asymptomatic and
erminal stages of SIV infection. Thus an overall de-
rease in CD31 T-cells was observed throughout the
ntire course of pathogenic SIV infection.
DISCUSSION
The gastrointestinal tract is an important portal of
ntry and early dissemination of HIV and SIV (Pantaleo
t al., 1991; Schneider et al., 1997; Stone et al., 1995).
ince GALT harbors the majority of lymphoid cells in
he body, it provides a microenvironment rich in acti-
ated cells for active viral replication (Nabel and Bal-
imore, 1987). The intestinal mucosa is substantially
nvolved in the initial early events of the viral–host
nteraction and disease progression (Schneider et al.,
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114 NDOLO ET AL.997). High viral loads have been reported in the
ntestinal tissues of SIV-infected macaques early in
he primary SIV infection (Heise et al., 1991, 1993a,b;
FIG. 3. The level of SIV infection (A), CD31 T-cell counts (B), and RANT
acaques infected with the pathogenic SIV isolate. In situ hybridizat
cores, cell counts, and RANTES mRNA expression, respectively.tone et al., 1995). The gastrointestinal tract has also seen shown to be a major site for early severe CD41
-cell depletion and dynamic immunophenotypic and
unctional changes in mucosal immune cells, empha-
NA expression (C) in jejunal tissues of uninfected controls and rhesus
unostaining, and QC-RT-PCR were used to determine SIV infectionES mR
ion, immizing the significance of early viral–immune interac-
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115RANTES GENE EXPRESSION IN SIV INFECTIONions in this lymphoid tissue (Mattapallil et al., 1998;
mit-McBride et al., 1998; Veazey et al., 1998).
Our study examined RANTES gene expression and the
revalence of SIV-infected cells and CD31 T-cells in
ntestinal mucosa of rhesus macaques infected with ei-
her pathogenic or nonpathogenic SIV isolates. We ex-
mined the correlation between these parameters during
he primary acute, asymptomatic, and SAIDS stages of
iral infection. We observed enhanced RANTES expres-
ion in rhesus macaques infected with either pathogenic
r nonpathogenic SIV isolates at various stages of dis-
ase progression. No clear correlation was observed
etween RANTES levels and viral loads in the intestinal
ucosa during the primary SIV infection and SAIDS
tages. Contradictory results have been reported on the
ANTES levels in peripheral blood samples of HIV-1-
nfected asymptomatic individuals and long-term nonpro-
ressors. Both high and low levels of RANTES were
eported in blood samples of HIV-1-infected nonprogres-
ors. A correlation between RANTES levels and low viral
oads has not clearly been established in these studies
Scala et al., 1997). In other studies, comparable RANTES
evels were detected in blood samples of HIV-1-infected
symptomatic individuals and AIDS patients (Kakkanaiah
t al., 1998; Kinter et al., 1998; Krowka et al., 1997). Our
esults suggest that alterations in RANTES gene expres-
ion in SIV-infected animals correlated with the patho-
enicity of the infecting virus. No correlation between
igh RANTES expression and low viral loads in intestinal
issues was found in these animals that could be indic-
tive of RANTES-mediated viral suppression in vivo. Al-
hough the mechanisms for the lack of such correlation
re not understood, various explanations may exist. The
icroenvironment of gut tissue is heterogeneous in na-
ure, harbors a variety of cells, and is distinct from the
ure cell cultures in vitro. Thus, the viral infection may
nvolve a variety of coreceptors other than CCR5 and
echanisms of viral entry. Therefore, RANTES levels
ay not be able to inhibit de novo infections in gut as
fficiently as in T-cell lines in vitro. The mechanisms of
iral suppression may be more complex and multifacto-
ial in gut tissue than in T-cell and macrophage cultures
n vitro.
The alterations in CD31 T-cells varied depending on
he pathogenicity of the SIV isolate and disease stage.
owever, no correlation was observed between the ex-
ression of RANTES and CD31 T-cells in the intestinal
ucosa. In particular, high RANTES expression and high
D31 T-cells counts were observed in the intraepithelial
nd lamina propria compartments at 1 and 2 weeks p.i.
uring the primary acute stage in animals infected with
onpathogenic SIV (Figs. 2B and 2C). The asymptomatic
tage in these animals was characterized by moderate
ANTES levels and low CD31 T-cell counts despite low
umbers of SIV-infected cells. Thus no correlation could
e deduced from these data between RANTES expres- Rion, CD31 T-cell prevalence, and number of SIV-infected
ells. The chemoattractant property of RANTES during
arly stages of acute inflammation induced by viral in-
ection may account for the increase in CD31 T-cells at 1
nd 2 weeks p.i. observed in nonpathogenic SIV infec-
ion. Lower numbers of CD31 T-cells were observed
uring the asymptomatic stage despite high RANTES
xpression. The role of increased levels of RANTES in
-cell recruitment at the site of viral infection in intestine
annot be explained. Similarly, in pathogenic SIV animals
he decline in CD31 T-cells observed starting at 2 weeks
.i. and progressing to the asymptomatic and terminal
hases did not corroborate previous data on the che-
oattractant and viral suppressor properties attributed
o high RANTES expression. Recently reported flow cy-
ometric analyses of isolated intraepithelial and lamina
ropria lymphocytes have shown a dramatic depletion of
D4 T-cells in gastrointestinal tissues of SIV-infected
hesus macaques (Mattapallil et al., 1998; Smit-McBride
t al., 1998; Veazey et al., 1998). Disruption of the lym-
hoid structure previously reported in SIV infections at
he terminal phase may account for the decline in T cells
nd low RANTES expression in animals with SAIDS.
Several mechanisms have been proposed to elucidate
ANTES-mediated control of HIV/SIV infection in vivo.
ANTES may directly suppress HIV/SIV infection through
ompetitive inhibition of CCR5 receptor (Cocchi et al.,
995, 1996). Second, the chemoattractant activity of RAN-
ES has been shown to modulate the recruitment of
-cells and macrophages at sites of viral infection (Ad-
ms and Lloyd, 1997). RANTES expression has also been
etected along with the expression of Th1 cytokine re-
ponse (IFN-g, IL-2) to infections. Thus an increase in
ANTES gene expression in intestine during primary SIV
nfection may be a part of early host responses to infec-
ion at the site. A slight increase in CD31 T-cells in both
ntraepithelial and lamina propria compartments was ob-
erved in two animals at 2 weeks following SIVmac 1A11
nfection. This could partly be attributed to an influx of
eripheral T-cells into the intestinal mucosa due to viral
nfection, suggesting that RANTES may be one of the
arly host factors to mediate altered leukocyte trafficking
n the intestinal mucosa observed in HIV/SIV infections.
his is supported by our previous studies that reported
ncreased cell adhesion molecule expression in intesti-
al tissue during SIV infection correlating with the patho-
enicity of the infecting virus (Stone et al., 1995).
Taken together our results demonstrate that in con-
rast to the viral suppression by RANTES observed in
itro, there was no direct correlation between high RAN-
ES gene expression and suppression of viral loads in
ntestinal lymphoid tissue. Thus RANTES expression in
he gut lymphoid tissue may not be a correlate for viral
uppression. However, the consistently high levels of
ANTES gene expression in primary SIV infection sug-
g
s
A
t
w
d
L
s
T
w
S
n
r
i
i
f
t
t
f
T
e
a
a
w
w
i
1
s
t
w
a
D
i
t
e
w
a
T
t
t
p
c
1
C
s
t
d
a
f
5
T
r
G
o
2
a
w
(
t
f
2
p
b
a
e
3
3
1
t
p
m
R
t
116 NDOLO ET AL.est that it may be part of the early host immune re-
ponse to viral infection.
MATERIALS AND METHODS
nimals, virus, and tissue collection
Twenty rhesus macaques (Macaca mulatta) housed at
he California Regional Primate Research Center, Davis,
ere used in this study. Animals were housed in accor-
ance with American Association for Accreditation of
aboratory Animal Care guidelines. These animals were
eronegative for simian retrovirus-1 (SRV-1) and simian
-cell leukemia virus-1 (STLV-1). The rhesus macaques
ere intravenously inoculated with either the pathogenic
IV isolates SIVmac 251 or SIVmac 239 (n 5 13) or with
onpathogenic SIVmac 1A11 (n 5 4). Animals were nec-
opsied at various time points following SIV infection and
ntestinal tissue samples were either immediately frozen
n liquid nitrogen for RNA isolation or fixed in buffered
ormalin and embedded in paraffin for in situ hybridiza-
ion and immunohistochemistry (Table 1). Tissue sec-
ions from the same intestinal tissue blocks were utilized
or both in situ hybridization and immunohistochemistry.
he animals infected with the pathogenic isolates were
uthanized during the primary acute stage at 1 (n 5 3)
nd 2 weeks p.i. (n 5 3) and at the asymptomatic stage
t 4 (n 5 2), 8 (n 5 1), and 23 weeks p.i. (n 5 1). Animals
TABLE 1
Disease Stages and Necropsy Time Points of Rhesus Macaques
Infected with either Pathogenic or Nonpathogenic SIV Isolates
Animal
No. SIV isolate
Necropsy
time point
(weeks p.i.)
Disease
stage
1 Control N/A N/A
2 Control N/A N/A
3 Control N/A N/A
4 SIVmac 1A11 1 Primary acute
5 SIVmac 1A11 2 Primary acute
6 SIVmac 1A11 13 Asymptomatic
7 SIVmac 1A11 23 Asymptomatic
8 SIVmac 251 1 Primary acute
9 SIVmac 251 1 Primary acute
10 SIVmac 251 1 Primary acute
11 SIVmac 251 2 Primary acute
12 SIVmac 251 2 Primary acute
13 SIVmac 239 2 Primary acute
14 SIVmac 251 4 Asymptomatic
15 SIVmac 251 4 Asymptomatic
16 SIVmac 251 8 Asymptomatic
17 SIVmac 251 12 SAIDS
18 SIVmac 239 23 SAIDS
19 SIVmac 251 27 SAIDS
20 SIVmac 251 35 SAIDS
Note. Three uninfected control animals were sacrificed and jejunal
issues were used in this study.ith SAIDS (n 5 3) were sacrificed at 12, 27, and 35 beeks p.i. The SIVmac 1A11-infected animals were sim-
larly sacrificed during the primary SIV infection at 1 (n 5
) and 2 weeks (n 5 1) p.i. and during the asymptomatic
tage at 13 (n 5 1) and 23 weeks p.i. (n 5 1). Jejunal
issues from three uninfected healthy animals (n 5 3)
ere included for baseline levels of CD31 T-cell counts
nd RANTES mRNA expression.
etection and localization of SIV-infected cells by
n situ hybridization
Intestinal tissue samples were examined for SIV infec-
ion by in situ hybridization as previously reported (Heise
t al., 1994). Briefly, SIV-infected cells in intestinal tissues
ere detected by in situ hybridization of SIV nucleic
cids with radiolabeled SIV-specific nucleic acid probes.
he slides were examined for the presence of SIV-posi-
ive cells. Each tissue section was scored semiquantita-
ively from 0 to 5 for SIV viral load as following: 0 (no
ositive cells), 1 (1 to 5 cells per a tissue section), 2 (1–5
ells/103 field), 3 (6–10 cells/103 field), 4 (11–15 cells/
03 field), and 5 (.15 cells/103 field).
onstruction of RANTES and GAPDH mimics
Composite primers were designed and used to con-
truct the internal competitors or mimics for the quanti-
ative-competitive PCR assay for RANTES and glyceral-
ehyde-3-phosphate dehydrogenase (GAPDH) based on
previously reported method (Heuvel et al., 1993). The
orward composite primer of 59 nt was composed of the
9-T7 promoter sequence, the v-erbB, and either RAN-
ES- or GAPDH-39-specific sequences respectively. The
everse composite primer contained 59-RANTES or
APDH and v-erbB sequences and oligo(dT)19-39. Sec-
nd, the gene-specific primer pairs were composed of
2-nt forward and reverse primers specific for GAPDH
nd RANTES, respectively (Fig. 1A and Table 2). PCRs
ere performed essentially as described previously
Siebert and Larrick, 1993) with the following modifica-
ion. A BamHI/EcoRI fragment of v-erbB DNA was ampli-
ied in a final volume of 50 ml containing 13 PCR buffer,
mM MgCl2, 0.4 mM each of forward and reverse com-
osite primers, a 0.2 mM concentration of each deoxyri-
onucleoside triphosphate, and 2.5 U Taq DNA polymer-
se (Promega, Madison, WI). The following cycle param-
ters were applied: an initial denaturation step 94°C for
min; 25 cycles of 94°C for 30 s, 60°C for 30 s, 72°C for
0 s. The PCR products were purified using Chromaspin-
00 columns (Clontech, Palo Alto, CA) and used as a
emplate for in vitro RNA transcription using T7 RNA
olymerase and a Ribomax in vitro transcription kit (Pro-
ega) according to the manufacturer’s instructions. The
NA was quantified by spectrophotometry and the num-
er of mRNA copies per microliter was determined.
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117RANTES GENE EXPRESSION IN SIV INFECTIONonstruction of plasmids containing simian GAPDH
r RANTES cDNA
Total RNA was isolated from jejunal tissue using stan-
ard procedures. GAPDH cDNA was generated by re-
erse transcription. A 527-bp PCR product was amplified
sing primers specific for a highly conserved region of
he GAPDH gene. The PCR product was subcloned into
CR 3.1 TA vector (Invitrogen) downstream of the T7
romoter. RNA transcripts were synthesized and used as
tandards in RT-PCRs according to the manufacturer’s
nstructions. A plasmid construct containing monkey
ANTES cDNA subcloned in pGEM vector (Promega)
as a generous gift from Francois Villinger (Emory Uni-
ersity).
reparation of GAPDH and RANTES RNA for internal
tandards
Standard RNA transcripts were generated as run-off
roducts by in vitro transcription of NotI linearized plas-
ids. The reaction mix was treated with RNase-free
Nase to digest template DNA. RNA transcripts were
xtracted once with Trizol (Gibco BRL, Grand Island, NY)
o remove any remaining DNA template and purified
sing Chromaspin columns as previously described.
easurement of RANTES mRNA by QC-RT-PCR
Reverse transcription was performed in a 20-ml final
eaction volume containing 13 PCR buffer, 5 mM MgCl2,
mM each deoxyribonucleotide triphosphate, 50 mM
andom primers, 1 U RNase inhibitor, and 1.25 U MMLV
everse transcriptase. A reverse transcription master mix
as prepared and aliquoted into seven replicates. One
icrogram of sample RNA per reaction and serial dilu-
ions (500,000 to 500 copies) of competitor mimic RNA
ere spiked into respective reactions. Samples were
ncubated at 42°C for 1 h. Reverse transcriptase was
nactivated by heating at 95°C for 5 min. After the inac-
ivation step, 30 ml of a PCR master mix containing 13
CR buffer, 2 mM MgCl, 0.2 mM deoxyribonucleotides,
.8 mM forward and reverse primers, and 2.5 U Taq DNA
olymerase were added to each of the cDNA samples,
ringing the final volume to 50 ml. The reactions were
T
Composite and Gene-Specific Primer Sequences
Forward RANTES mimic composite primer: 59-TAATACGACTCAC
Reverse RANTES mimic composite primer: 59-TTTTTTTTTTTTTTT
Forward GAPDH mimic composite primer: 59-TAATACGACTCACT
Reverse GAPDH mimic composite primer: 59-TTTTTTTTTTTTTTTT
Forward RANTES gene-specific primer: 59-CATATTCCTCGGACAC
Reverse RANTES gene-specific primer: 59-CTCCAAGAGTTGATGT
Forward GAPDH gene-specific primer: 59-ACCACCATGGAGAAGG
Reverse GAPDH gene-specific primer: 59-CTCAGTGTAGCCCAGGenatured at 94°C for 3 min and subjected to 25 thermal tycles as follows: a denaturing step at 94°C for 30 s,
nnealing at 60°C for 30 s, and extension at 72°C for
0 s using a GeneAmp PCR system 9600 Thermal cycler
Perkin–Elmer). A 10-ml aliquot from each PCR product
as resolved on a 3% metaphor agarose gel (FMC Bio-
roducts, Rockland, ME) and visualized by ethidium bro-
ide staining. Relative intensities of the 192- and 342-bp
CR product bands corresponding to RANTES and
imic as well as the 527- and 340-bp products for
APDH target and mimic, respectively, were captured,
orrected for the difference in size, and quantified by
omputer imaging using the NIH image analysis soft-
are. The log ratio of target to mimic was plotted against
he log ratio of mimic copies to determine the corre-
ponding number of RANTES or GAPDH mRNA copies in
mg total RNA.
etection and localization of CD31 T-cells by
mmunohistochemistry
For the detection of CD31 T-cells, formalin-fixed par-
ffin-embedded jejunal tissue sections were immuno-
tained using anti-CD3 antibody (Dako) as previously
escribed (Heise et al., 1993b). To determine the CD31
-cell counts in the epithelial and lamina propria com-
artments, slides were microscopically examined and
mages were digitally scanned and captured using
dobe Photoshop. Villus sizes were determined by su-
erimposing the selected images on a prescanned he-
ocytometer grid (0.05 mm2). The number of CD31 T-
ells in the intraepithelial and lamina propria compart-
ents was counted in a 4.4-mm villus length for the
ntraepithelial compartment and in a 2.05-mm villus
ength for the lamina propria compartments, respectively.
t least 10 villi were counted per animal and the average
umbers of cells were expressed as the number of CD31
-cells in the respective compartments per linear length
in millimeters) of villus.
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